Patel Sanj K sold KNSA
November 3, 2026 · Form 4 insider transaction
Patel Sanj K sold 145,708 shares of Kiniksa Pharmaceuticals International, plc at $93.53 per share, a transaction worth $13.63M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
145,708
Price
$93.53
Total value
$13.63M
InsiderPatel Sanj K
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 3, 2026
Filing dateNovember 3, 2026
Shares owned after784,621
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $93.085 and $94.00. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.